Biotage AB said Torben Jørgensen is stepping down as the company's CEO in 2020.
Jørgensen has been Biotage's CEO since 2006 and his employment contract will expire April 2020. He will continue with his role until a replacement is named by the company.
Biotage noted it has started the recruitment process for a new CEO.
The company proposed the election of Jørgensen as director at its upcoming annual general meeting scheduled on April 24.
Sweden-based Biotage is a life science company that develops solutions for use in organic and analytical chemistry, and for industrial applications.